Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Adam R. Wolfe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0123-7371; OpenAlex author ID A5030652856. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 11

  1. Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1. Last author DOI 10.1016/j.radonc.2024.110531↗
  2. Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions. Co-author DOI 10.1126/sciadv.adj3551↗
  3. Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq. Last author DOI 10.20517/cdr.2022.60↗
  4. Morphologic changes associated with neoadjuvant-treated pancreatic ductal adenocarcinoma and comparison of two tumor regression grading systems. Co-author DOI 10.1016/j.humpath.2020.11.010↗
  5. Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic can… Co-author DOI 10.1016/j.radonc.2021.02.035↗
  6. Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic… Co-author DOI 10.1158/1078-0432.ccr-20-1422↗
  7. Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13205168↗
  8. Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgic… Co-author DOI 10.1002/cam4.3075↗
  9. A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection. Co-author DOI 10.18632/oncotarget.27496↗
  10. Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report. Co-author DOI 10.1016/j.adro.2018.08.025↗
  11. Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence. Co-author DOI 10.21037/apc.2018.08.02↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Terence Marques Williams · 9 shared papers, 2018–2024 · strength 1.18
  2. Óscar Zúñiga · 2 shared papers, 2022–2024 · strength 0.50
  3. Ryan N. Robb · 4 shared papers, 2020–2024 · strength 0.49
  4. Mary E. Dillhoff · 4 shared papers, 2020–2021 · strength 0.43
  5. Wendy L. Frankel · 3 shared papers, 2020–2021 · strength 0.37
  6. Wei Chen · 2 shared papers, 2021–2024 · strength 0.34
  7. Jordan M. Cloyd · 3 shared papers, 2020–2021 · strength 0.33
  8. Laith I. Abushahin · 3 shared papers, 2020–2021 · strength 0.33
  9. Wei Chen · 3 shared papers, 2020–2021 · strength 0.31
  10. Stetson Van Matre · 1 shared paper, 2024 · strength 0.24
  11. Allan Tsung · 2 shared papers, 2021 · strength 0.23
  12. Eric David Miller · 2 shared papers, 2020–2021 · strength 0.22
  13. Anne M. Noonan · 2 shared papers, 2020–2021 · strength 0.21
  14. Nikhil Sebastian · 2 shared papers, 2020–2021 · strength 0.21
  15. Jennifer L. Vazzano · 1 shared paper, 2021 · strength 0.17
  16. Joanna M. Karasinska · 1 shared paper, 2024 · strength 0.16
  17. Michael P. Lisanti · 1 shared paper, 2024 · strength 0.16
  18. James Thomas Topham · 1 shared paper, 2024 · strength 0.16
  19. David F. Schaeffer · 1 shared paper, 2024 · strength 0.16
  20. Daniel John Renouf · 1 shared paper, 2024 · strength 0.16
  21. Jon P. Walker · 1 shared paper, 2019 · strength 0.12
  22. Rishi Jain · 1 shared paper, 2019 · strength 0.12
  23. Timothy Michael Pawlik · 1 shared paper, 2019 · strength 0.12
  24. Ahmad Hegazi · 1 shared paper, 2021 · strength 0.12
  25. Zobeida Cruz‐Monserrate · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.